Literature DB >> 3298135

Alpha interferon: a look to the future.

E M Bonnem.   

Abstract

The alpha-interferons have been explored in a wide variety of clinical applications in cancer. Significant activity has been demonstrated in AIDS-related Kaposi's sarcoma, ovarian carcinoma, bladder carcinoma, malignant glioma, non-Hodgkin's lymphoma, chronic granulocytic leukemia, the carcinoid syndrome and hairy cell leukemia. Although these leads are promising, the research has only just begun.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3298135     DOI： 10.1007/BF00207265

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


  41 in total

1.  Potentiation of interferon action by mixtures of recombinant DNA-derived human interferons.

Authors:  W R Fleischmann; C M Fleischmann; W Fiers
Journal:  Antiviral Res       Date:  1984-12       Impact factor: 5.970

2.  [Combined effects of 5-fluorouracil and interferon on proliferation of human neoplastic cells in culture].

Authors:  T Miyoshi; S Ogawa; T Kanamori; M Nobuhara; T Kimoto; M Namba
Journal:  Gan To Kagaku Ryoho       Date:  1982-12

3.  Modulation by a human interferon of antitumor effects of cyclophosphamide against a lymphosarcoma in hamsters.

Authors:  S H Lee; H Chiu; K W Renton; N Stebbing
Journal:  Biochem Pharmacol       Date:  1984-11-01       Impact factor: 5.858

4.  Potentiation of the antiviral and anticellular activities of interferons by mixtures of HuIFN-gamma and HuIFN-alpha or HuIFN-beta.

Authors:  E Oleszak; W E Stewart
Journal:  J Interferon Res       Date:  1985

5.  Inhibition of mouse bladder tumor proliferation by murine interferon-gamma and its synergism with interferon-beta.

Authors:  T L Ratliff; D Kadmon; A Shapiro; A J Jacobs; W D Heston
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

6.  Systemic IFN-alpha treatment of multiple bladder papilloma grade I or II patients: pilot study.

Authors:  C H Scorticatti; N C de de la Peña; O G Bellora; R A Mariotto; A R Casabé; R Comolli
Journal:  J Interferon Res       Date:  1982

7.  [Current status of interferon therapy on malignant brain tumor].

Authors:  M Nagai; T Arai; S Kohno; E Iizuka
Journal:  Gan No Rinsho       Date:  1983-05

8.  Leukocyte interferon (IFN alpha) in patients with epithelial ovarian carcinoma.

Authors:  R S Freedman; J U Gutterman; J T Wharton; F N Rutledge
Journal:  J Biol Response Mod       Date:  1983

9.  Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters.

Authors:  E P Gelmann; O T Preble; R Steis; H C Lane; A H Rook; M Wesley; J Jacob; A Fauci; H Masur; D Longo
Journal:  Am J Med       Date:  1985-05       Impact factor: 4.965
View more
  1 in total

1.  Local immunotherapy (beta-IFN) and systemic chemotherapy in primary glial tumors.

Authors:  A Boiardi; A Silvani; I Milanesi; L Munari; G Broggi; M Botturi
Journal:  Ital J Neurol Sci       Date:  1991-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.